Articles related to VISION/OCULAR HEALTH

AI-enabled retinal imaging platforms are being deployed across healthcare settings to identify ocular and systemic disease signals, though the role of these technologies continues to evolve alongside regulatory approvals and clinical validation.

TFOS DEWS III proposes a driver-based approach to dry eye disease, emphasizing standardized diagnosis, disease subtyping, and layered treatment strategies matched to underlying mechanisms rather than rigid severity-based escalation.

The FDA classified the nationwide recall of more than 2.5 million bottles of Lupin’s prednisolone acetate ophthalmic suspension as a Class II recall after reports of a foreign substance in affected products.

Each additional hour of daily digital screen exposure was associated with 21% higher odds of myopia in a 335,524-participant meta-analysis, with the steepest odds increase observed between 1 and 4 hours of daily exposure, though substantial heterogeneity and cross-sectional study designs precluded causal conclusions.

Researchers at the National University of Singapore developed a spinach-derived nanotechnology delivering plant photosynthetic machinery into corneal cells via eye drops, demonstrating reversal of corneal damage to near-healthy levels within five days in preclinical models of dry eye disease.

A case-control study identified covert mortality nodavirus, previously known only in aquatic animals, in iris tissue of patients with persistent ocular hypertensive viral anterior uveitis, with exposure risk concentrated among those who handle or consume raw aquatic animals daily.